TNGX - Tango Therapeutics, Inc.

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
8.54 1.16 (13.58%)	---	---	0.0 (0.0%)	0.17 (1.99%)	0.79 (9.04%)	0.0 (0.0%)	0.0 (0.0%)

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.35
Diluted EPS:: -0.35
Basic P/E:: -27.7143
Diluted P/E:: -27.7143
RSI(14) 1m:: 100.0
VWAP:: 9.7
RVol:: 0.8856

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	9.7 +0.18 (+1.89%)	Oct 15 18:21
Day	Price increase day	9.43 +0.89 (+10.36%)	Oct 15 14:52
1m	Price increase 1m	9.34 +0.12 (+1.3%)	Oct 15 13:58
1m	Price increase 1m	9.18 +0.11 (+1.16%)	Oct 15 11:39
1m	Price decrease 1m	8.75 -0.12 (-1.3%)	Oct 15 09:31